ANDA 74168, held by Ivax Sub Teva Pharms. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 74168 (Diltiazem Hydrochloride), held by Ivax Sub Teva Pharms, was first approved by FDA on Mar 3, 1995, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 3, 1995 | Original application | Approved | None posted |
| Diltiazem Hydrochloride30MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride60MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride90MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Diltiazem Hydrochloride120MG · tablet;oral | Diltiazem Hydrochloride | Discontinued |
| Jan 28, 2000 | Supplement 2Manufacturing | Approved | None posted |
| Mar 3, 1995 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters